US · Healthcare

BioXcel Therapeutics Inc (BTAI)

Drug Manufacturers - Specialty & Generic

BioXcel Therapeutics Inc (BTAI) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BTAI

P/E ratio

18.00

BioXcel Therapeutics Inc (BTAI) — FAQ

What is BTAI's P/E ratio?

The price-to-earnings (P/E) ratio for BioXcel Therapeutics Inc (BTAI) is 18.00 (data as of 2026-03-23).

Does BioXcel Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for BioXcel Therapeutics Inc (BTAI). Check the MyAverix Finance app for the latest dividend data.

What sector is BioXcel Therapeutics Inc in?

BioXcel Therapeutics Inc (BTAI) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is BTAI listed on?

BTAI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)